Home・Stock List・Pulmatrix Inc

Pulmatrix Inc

Closed

1.36 -0.73

Buy Sell

Overview

Share price change

24h

Current

Min

1.3599999999999999

Max

1.42

Key metrics
By Trading Economics
Income	136K -1M
EPS	-0.29
Employees	2
EBITDA	126K -1M

Market Stats
By TradingEconomics
Market Cap	-438K 5.3M
Previous open	2.09
Previous close	1.36

Pulmatrix Inc Chart

Past performance is not a reliable indicator of future results.

Related News

20 Sept 2026, 23:51 UTC

BoJ Meeting Minutes on September 27 Expected to Influence Japan's Interest Rate Outlook Amid Global Economic Uncertainties.

20 Sept 2026, 23:11 UTC

PBOC Holds Loan Prime Rate Steady at 3.00% Amid Economic Caution and Mixed Signals in China

20 Sept 2026, 23:01 UTC

Macro News

Correlated Moves

The Dow Jones Index is advancing as the People's Bank of China maintains its Loan Prime Rates amid cautious market conditions and geopolitical tensions.

20 Sept 2026, 23:01 UTC

Correlated Moves

Macro News

The S&P 500 Index is advancing amid macroeconomic developments, including China's unchanged Loan Prime Rates and mixed industrial production and retail sales data.

20 Sept 2026, 23:01 UTC

Macro News

Correlated Moves

The Nasdaq 100 Index is advancing, supported by the Russell 2000's rise and the People's Bank of China's decision to maintain its Loan Prime Rate at 3.00%.

20 Sept 2026, 23:01 UTC

Correlated Moves

Macro News

The Russell 2000 Index is modestly higher, reflecting a stable market backdrop amid China's unchanged Loan Prime Rate and geopolitical tensions.

20 Sept 2026, 23:00 UTC

Macro News

Oil (WTI) is advancing amid heightened geopolitical tensions following Houthi attacks in Saudi Arabia and ongoing U.S. energy policy discussions, despite earlier session pullbacks.

20 Sept 2026, 23:00 UTC

The EUR/NOK is declining as trading resumes for the week, influenced by ongoing geopolitical tensions in the Middle East and U.S.-Iran relations.

20 Sept 2026, 23:00 UTC

The EUR/CHF is slightly lower in early trading this week, reflecting routine fluctuations amid ongoing geopolitical tensions, particularly in the Middle East.

20 Sept 2026, 23:00 UTC

The EUR/CZK is slightly lower as trading resumes for the week, reflecting geopolitical tensions affecting financial markets despite remaining near the upper end of its one-month range.

20 Sept 2026, 23:00 UTC

Avalanche is experiencing a sharp increase in value, maintaining a position well above its 20-day moving average amid ongoing geopolitical tensions.

20 Sept 2026, 22:51 UTC

U.S. 30-Year Mortgage Rate Hits Highest Level Since May at 6.97%, Sparking Concerns Over Housing Demand Amid Rising Treasury Yields and Inflation Fears

20 Sept 2026, 22:51 UTC

Chicago Fed National Activity Index Release on September 21, 2026, Anticipates Continued Economic Uncertainty Amid Recent Volatility.

20 Sept 2026, 22:11 UTC

UK Consumer Confidence Index Set for Release Amid Mixed Sentiment and Economic Concerns, Forecast at -16.0

20 Sept 2026, 22:01 UTC

Correlated Moves

The AUD/USD is slightly lower in early trading, reflecting a cautious investor outlook amid ongoing Middle East conflict and recent interest rate hikes.

20 Sept 2026, 22:00 UTC

The EUR/PLN is advancing in early trading, reflecting a notable increase since Friday's close amid ongoing geopolitical tensions and central bank interest rate hikes.

20 Sept 2026, 21:21 UTC

Australia's S&P Global Manufacturing PMI Flash set for September 22, with cautious optimism amid global economic pressures.

20 Sept 2026, 21:21 UTC

Australia's S&P Global Services PMI Flash set for September 22, with cautious optimism amid global market influences.

20 Sept 2026, 21:01 UTC

Brazil's Central Bank to Release Key Market Readout on Interest Rates and Economic Forecasts on September 21, 2026.

20 Sept 2026, 20:51 UTC

UK CBI Distributive Trades Forecasts Sharp Decline in Retail Sales Sentiment at -50.0 Amid Ongoing Consumer Spending Downturn

20 Sept 2026, 20:21 UTC

UK Factory Orders Show Resilience with Improved Order Book Balance, Yet Forecasts Indicate Continued Decline Amid Economic Challenges.

20 Sept 2026, 20:21 UTC

API Crude Oil Stock Change Report on September 22, 2026, Expected to Reveal Rising U.S. Inventories Amid Geopolitical Tensions Impacting Market Sentiment.

20 Sept 2026, 19:21 UTC

South Korea's Consumer Confidence Index Release on September 22 Expected to Reflect Cautious Optimism Amid Economic Volatility.

20 Sept 2026, 18:51 UTC

Germany's Ifo Business Climate Index set to release with a forecast of 89.2, reflecting cautious optimism amid geopolitical tensions and inflationary pressures.

20 Sept 2026, 18:51 UTC

South Africa's Inflation Rate MoM Release on September 23, 2026 Expected to Reflect Global Economic Trends Amid Rising Concerns.

20 Sept 2026, 18:51 UTC

South Africa's Inflation Rate Release on September 23, 2026, Expected to Reflect Economic Pressures Amid Rising Costs and Geopolitical Tensions.

20 Sept 2026, 18:41 UTC

Cautious Optimism for Euro Area Manufacturing as S&P Global PMI Flash Set to Show Growth at 52.9 Amid Geopolitical Challenges

20 Sept 2026, 18:41 UTC

Spain's Balance of Trade Data Set for Release Amidst Ongoing Trade Deficits and Rising Import Costs, Raising Inflation Concerns in the Eurozone.

20 Sept 2026, 18:41 UTC

Swiss National Bank Expected to Maintain Zero Interest Rate Amid Subdued Inflation and Modest Economic Growth

20 Sept 2026, 18:41 UTC

French Services PMI Flash Expected at 48.5 Amid Political and Economic Concerns, Signaling Continued Contraction

Peer Comparison

Price change

Pulmatrix Inc Forecast

Rating Consensus

By TipRanks

0 ratings

Buy

Hold

Sell

Based on 0 analysts giving stock ratings to Pulmatrix Inc - Dist in the past 3 months.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Pulmatrix Inc

Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates. The company was founded in 2003 and is headquartered in Bedford, Massachusetts.